Syndax Pharmaceuticals, Inc. Repayments of Long-term Capital Lease Obligations
Syndax Pharmaceuticals, Inc. (SNDX) reported Repayments of Long-term Capital Lease Obligations of $1.00 thousand for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermCapitalLeaseObligations · last filed 2016-05-16
- Syndax Pharmaceuticals, Inc. repayments of long-term capital lease obligations for the quarter ending 2016-03-31 was $1.00K, a 0.00% change year-over-year.
- Syndax Pharmaceuticals, Inc. repayments of long-term capital lease obligations for the quarter ending 2015-03-31 was $1.00K.
| Period end | Repayments of Long-term Capital Lease Obligations 3 month |
|---|---|
| 2016-03-31 | $1.00K 10-Q · filed 2016-05-16 |
| 2015-03-31 | $1.00K 10-Q · filed 2016-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |